Literature DB >> 32448099

Clinical, esthetic, and quality of life outcomes after telegnathic surgery in Caucasian OSAS patients.

Maite Barbero González1, Joan Brunsó Casellas2, María Pilar Fernández Mondragón3, Valentín Cabriada Nuño4, Julio Alvarez Amezaga2,3, Felix De Carlos Villafra1.   

Abstract

Objective: To carry out both an objective and subjective assessment of the facial esthetics, clinical outcome, and quality of life evaluation in 25 OSAS patients treated with telegnathic surgery.
Methods: Patients were analyzed using AHI, Legan and Burstone and airway cephalometric analysis for the objective study together with youthful and esthetic perception and SF-36 health surveys for the subjective part.
Results: Facial convexity, nasolabial and lower face-throat angle, upper lip protrusion, and vertical height-depth ratio improved the facial and neck esthetics, while the maxillary and mandibular prognathism increased. Eighty-eight percent considered an esthetic change on their facial profile and 52% a more youthful profile. FS-36 survey (pre- 48.86 and post-surgery 71.74) and AHI (pre- 41.32 and post-surgery 7.80) scores improved significantly.Discussion: Results after telegnathic surgery were both esthetically and clinically satisfactory. The FS-36 survey should be considered for monitoring treatment in OSAS patients.

Entities:  

Keywords:  Facial profile; OSAS; SF-36 health survey; maxillomandibular advancement; sleep apnea; telegnathic surgery

Mesh:

Year:  2020        PMID: 32448099     DOI: 10.1080/08869634.2020.1767474

Source DB:  PubMed          Journal:  Cranio        ISSN: 0886-9634            Impact factor:   1.670


  1 in total

1.  Post-Operative Patients' Satisfaction and Quality of Life Assessment in Adult Patients with Obstructive Sleep Apnea Syndrome (OSAS).

Authors:  Diego Sergio Rossi; Funda Goker; Federico Cullati; Alessandro Baj; Daniele Pignatelli; Aldo Bruno Gianni; Massimo Del Fabbro
Journal:  Int J Environ Res Public Health       Date:  2022-05-21       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.